Skip to main content

Table 3 Effects of turmeric on serum levels of lipid profile and malondialdehyde in patients with NAFLD

From: The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Variables Placebo, n = 32 Turmeric, n = 32 P1
Triglycerides (mg/dL)
 Before 176.44 ± 91.96 164.34 ± 80.12 0.577
 After 155.62 ± 85.35 141.78 ± 65.57 0.470
 P2 0.188 0.043  
Total Cholesterol (mg/dL)
 Before 194.50 ± 34.29 195.88 ± 35.38 0.875
 After 182.62 ± 29.36 186.50 ± 36.49 0.641
 P2 0.143 0.196  
LDL (mg/dL)
 Before 116.52 ± 27.11 121.93 ± 28.77 0.442
 After 104.60 ± 22.99 108.40 ± 26.83 0.545
 P2 0.052 0.035  
HDL (mg/dL)
 Before 42.45 ± 10.17 40.28 ± 6.66 0.316
 After 44.59 ± 7.17 42.34 ± 4.13 0.129
 P2 0.247 0.049  
VLDL(mg/dL)
 Before 36.17 ± 14.82 30.88 ± 15.02 0.161
 After 33.63 ± 16.55 32.53 ± 16.52 0.791
 P3 0.394 0.417  
Cholesterol/HDL ratio
 Before 4.71 ± .0.97 5.03 ± 1.37 0.294
 After 4.16 ± 0.80 4.45 ± 1.00 0.211
 P2 0.012 0.021  
LDL/HDL ratio
 Before 2.81 ± 0.72 3.12 ± 0.94 0.155
 After 2.38 ± 0.59 2.57 ± 0.66 0.235
 P2 0.005 0.003  
MDA(mmol/L)
 Before 0.278 ± 0.14 0.237 ± 0.13 0.241
 After 0.189 ± 0.13 0.167 ± 0.10 0.487
 P2 0.191 0.000  
  1. Values presented as mean ± SD
  2. NAFLD nonalcoholic fatty liver disease, LDL low-density lipoprotein, HDL high-density lipoprotein, VLDL very low-density lipoprotein, Unit µM/L
  3. a,bP values indicate differences between the intervention and placebo groups at before and after intervention (Paired T Test)